Swissmedic - Swiss Agency for Therapeutic Products

11/19/2026 | News release | Distributed by Public on 11/19/2026 08:09

Advance notice: New notification process from 4 January 2027 for complementary medicinal products without indication under the notification procedure

19.11.2026

On 4 January 2027 Swissmedic is switching the process for the notification procedure for complementary medicines without indication. In future, single notifications will be recorded and newly applied for via the Swissmedic Portal. In this context, the existing "HOMANT" application will be decommissioned on 31 December 2026.
This switch, which is part of Swissmedic's ongoing digitalisation initiative and the modernisation of the application landscape, will affect all newly submitted single notifications (relating to new and ongoing applications for the new authorisation of complementary medicines under the notification procedure) as well as new authorisations of master dossiers. Companies are asked to take the upcoming changes into account in their planning.
Further information on the new process, the technical requirements and the transitional rulings will be available on our Swissmedic website prior to the switch.

Swissmedic - Swiss Agency for Therapeutic Products published this content on November 19, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 19, 2026 at 14:09 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]